TickerFacts.

InMed Pharmaceuticals Inc. (INM): Operating Income

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest Operating Income is for the year ended 2023-06-30, while the company's latest annual report covers the year ended 2026-06-30. Its later filings do not report this line under the concept TickerFacts maps.

-$7.95M
Year ended 2023-06-30
2021-06-30: -$10.20M2022-06-30: -$18.60M2023-06-30: -$7.95M-$7.95M
2021-06-30 Operating Income (USD) 2023-06-30
Period endedOperating IncomeChange YoYSource filing
2023-06-30-$7.95Mn/m2023-09-29, From 2022-07-01
2022-06-30-$18.60Mn/m2023-09-29, From 2021-07-01
2021-06-30-$10.20Mn/a2022-09-23, From 2020-07-01